AMANDA KEYS: Open Payments
NPI 1215145164 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 51 payments from 11 companies in 2025. Trend: 2023 $7,146 · 2024 $4,505 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $177 |
| Abbott Laboratories | 3 | $157 |
| Novartis Pharmaceuticals Corporation | 9 | $149 |
| E.R. Squibb & Sons, L.L.C. | 11 | $149 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $99 |
| Boston Scientific Corporation | 2 | $75 |
| Amgen Inc. | 4 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $61 |
| Novo Nordisk Inc | 3 | $55 |
| Kestra Medical Technology Services, Inc. | 1 | $35 |
Products named: ELIQUIS, CARDIOMEMS, LEQVIO, LifeVest, CAMZYOS, WATCHMAN, REPATHA, EVKEEZA.
Industry payments across LA — which companies pay providers there.
